1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Mumps: new trials by email Literature Review of Mumps trials Research Report on Mumps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults CVM150, CVM26, Placebo - Mumps | Phase 1 | Active not recruiting | CyanVac LLC | 60 | 2025-05-14 | 2025-12-11 |
| A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children 3.50±0.25logCCID50/ml, 4.25±0.25 logCCID50/ml, 5.00±0.25 logCCID50/ml - Mumps | Phase 1 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 300 | 2012-10-01 | 2023-10-10 |
| Immune Responses to Two Dose Varivax +/- MMR-II MMR-II, Pro-Quad, Varivax - Measles, Mumps | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 105 | 2005-10-01 | 2010-08-27 |
Chickenpox (1) · Measles (1) · Rubella (1)
Infections (3) · Mononegavirales Infections (3) · Mouth Diseases (3) · Paramyxoviridae Infections (3) · Parotid Diseases (3) · Parotitis (3) · RNA Virus Infections (3) · Rubulavirus Infections (3) · Salivary Gland Diseases (3) · Stomatognathic Diseases (3) · Virus Diseases (3) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Morbillivirus Infections (1) · Rubivirus Infections (1)
Chickenpox Vaccine (1) · Long-Term Synaptic Depression (1)
CyanVac LLC (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · China (1)
Hong Jin (1) · Yuliang Zhao, Master (1)